The Arab Drug Company (EGX:ADCI)

Egypt flag Egypt · Delayed Price · Currency is EGP
154.21
0.00 (0.00%)
At close: Mar 27, 2025
64.02%
Market Cap 925.26M
Revenue (ttm) 929.75M
Net Income (ttm) 122.99M
Shares Out 6.00M
EPS (ttm) 20.50
PE Ratio 7.52
Forward PE n/a
Dividend 8.35 (5.41%)
Ex-Dividend Date Oct 28, 2024
Volume 1,163
Average Volume 2,982
Open 154.21
Previous Close 154.21
Day's Range 162.55 - 167.00
52-Week Range 76.02 - 186.50
Beta 0.66
RSI 52.72
Earnings Date May 29, 2025

About The Arab Drug Company

The Arab Drug Company engages in the manufacture and sale of pharmaceutical products. It offers anti-infectives, central nervous system drugs, dermatological drugs, and cardiovascular drugs, as well as animal health products in powders and solutions. The company exports its products to approximately 40 countries, including China, Korea, Turkey, Kazakhstan, Iraq, Syria, Jordan, Lebanon, Libya, Sudan, Somalia, Yemen, and Morocco. The Arab Drug Company was incorporated in 1963 and is based in Cairo, Egypt. [Read more]

Industry Pharmaceutical Preparations
Founded 1963
Employees 1,148
Stock Exchange Egyptian Stock Exchange
Ticker Symbol ADCI
Full Company Profile

Financial Performance

In 2024, The Arab Drug Company's revenue was 785.52 million, an increase of 23.95% compared to the previous year's 633.73 million. Earnings were 88.35 million, an increase of 24.21%.

Financial Statements

News

There is no news available yet.